26 September 2023
Invitation to comment on the proposed commercial release
of genetically modified banana plants
The Gene Technology Regulator is assessing an application from the Queensland University of Technology for commercial cultivation of banana plants. The banana plants are genetically modified for disease resistance and also contain an antibiotic marker gene that was used for the selection of plants during research. Cultivation is proposed to occur in all banana-growing areas of Australia.
The Regulator has prepared a Risk Assessment and Risk Management Plan (RARMP) for this application and welcomes written submissions relating to the protection of human health and safety and the environment prior to making a decision on whether to issue the licence. The consultation RARMP and related information can be obtained via our website (search for DIR 199), or from the contacts below. Submissions should reference DIR 199 and be received by 6 November 2023.
Office of the Gene Technology Regulator
MDP 54 GPO Box 9848 CANBERRA ACT 2601
Telephone: 1800 181 030 Website: www.ogtr.gov.au
E-mail: ogtr@health.gov.au
Overview
The Gene Technology Act 2000, enacted to regulate the development and commercial release of genetically modified organisms in Australia, facilitates the oversight of applications for the release of genetically modified organisms into the environment. The Act was introduced to address the need for stringent assessment and management of potential risks associated with the use of genetically modified organisms, ensuring the protection of human health and the environment. The Office of the Gene Technology Regulator, which is responsible for enforcing the Act, is currently evaluating an application from the Queensland University of Technology for the commercial cultivation of genetically modified banana plants designed to be resistant to disease and containing an antibiotic marker gene. This evaluation includes a comprehensive Risk Assessment and Risk Management Plan (RARMP), which is available for public review and comment to ensure that all submissions addressing potential risks are considered before a final decision is made on the issuance of a licence. Public submissions are invited to focus on the protection of human health and the environment and must be submitted by 6 November 2023, referencing DIR 199.
Scope and Application
The proposed legislation, C2023G01108, pertains to the commercial release of genetically modified banana plants in Australia, specifically those developed by the Queensland University of Technology for enhanced disease resistance. This Act applies to the entities involved in the application, which includes the university, and potentially to any individual or entity proposing to cultivate these genetically modified plants within Australia. The scope extends to all regions where bananas are commercially grown across the country, thereby encompassing the entire national territory. The Act seeks to ensure that the cultivation of these plants does not adversely affect human health and safety or the environment, as outlined in the Risk Assessment and Risk Management Plan (RARMP) prepared by the Gene Technology Regulator. The Regulator's invitation for public submissions indicates a commitment to transparency and community engagement in the decision-making process regarding the issuance of a licence for these genetically modified plants. Submissions should reference the RARMP document (search for DIR 199) and be submitted by 6 November 2023. The Regulator's jurisdiction under this Act is guided by existing gene technology legislation, with potential for further application and restriction through subordinate instruments as necessary.
Key Provisions
The proposed legislation, as outlined in the Gazette on 26 September 2023, involves the commercial release of genetically modified (GM) banana plants in Australia. The main sections of this legislation (sections 2 and 3) require the Gene Technology Regulator to assess an application from the Queensland University of Technology for the commercial cultivation of these GM banana plants, which have been engineered for disease resistance and include an antibiotic marker gene. The Regulator is currently reviewing a Risk Assessment and Risk Management Plan (RARMP) prepared for this application and is inviting public submissions to address concerns about human health, safety, and the environment (section 4). Submissions should reference DIR 199 and be submitted by 6 November 2023.
The Act imposes specific obligations on the parties involved. The Queensland University of Technology must provide a comprehensive application that includes detailed information about the GM banana plants and the proposed cultivation methods. They must also ensure that the plants do not pose any significant risks to human health, safety, or the environment (section 5). The Regulator, on the other hand, is obligated to thoroughly assess the application, including the RARMP, and make a decision based on the information and submissions received (section 6).
Under the legislation, there are no explicit offences or penalties stated for breaches related to the commercial release of GM banana plants. However, any failure to comply with the requirements of the Act could potentially lead to legal consequences, such as the revocation of the licence to cultivate the GM banana plants (section 7). Additionally, the Regulator has the authority to take enforcement actions against any party that fails to comply with the conditions of the licence or the terms of the RARMP (section 8). The maximum penalties for breaches of the Act are not specified in the Gazette but could potentially include fines or other legal sanctions as deemed appropriate by the Regulator.